MiNK Therapeutics, Inc.
INKT· Nasdaq
INKTMiNK Therapeutics, Inc.
Filed May 15, 2026 · 10-Q · 45 days after period end · 0001193125-26-226804
| Metric | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 |
|---|---|---|---|---|
| Net Income | -$2.74M | -$2.77M | -$3.81M | -$5.69M |
| EPS Diluted | -$0.57 | -$0.70 | -$0.11 | -$0.17 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
MiNK Therapeutics, Inc. · CIK 1840229 · Engraved from SEC EDGAR
ended Mar 31, 2026 · filed May 15, 2026 · 45 d after period end
